Lista de obras -

A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis

scientific article published on 22 November 2017

Acute hepatitis C in a nursing home resident

scientific article published on 01 March 2005

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.

artículo científico publicado en 2016

An alcoholic patient who continues to drink: case presentation.

artículo científico publicado en 2006

An alcoholic patient who continues to drink: case progression

artículo científico publicado en 2006

Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?

scientific article published on 01 June 2013

Barriers and Facilitators to Mediterranean Diet Adoption by Patients with Non-alcoholic Fatty Liver Disease in Northern Europe

artículo científico publicado en 2018

Care standards for non-alcoholic fatty liver disease in the United Kingdom 2016: a cross-sectional survey

artículo científico publicado en 2017

Changing epidemiology of chronic liver disease among ethnic groups in the United States.

artículo científico publicado en 2016

Convalescent plasma therapy for persistent hepatitis E virus infection

scientific article published on 08 May 2019

Decompensated alcohol related liver disease: acute management.

artículo científico publicado en 2016

Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention Mapping

artículo científico publicado en 2020

Distance to treatment as a factor for loss to follow up of hepatitis C patients in North East England

article

Editorial: NAFLD in Asia-clinical associations with advanced disease become clearer

artículo científico publicado en 2018

Editorial: further evidence for the use of advanced magnetic resonance imaging techniques to monitor NAFLD.

artículo científico publicado en 2017

Editorial: improving in-hospital management of decompensated cirrhosis by a 'care bundle' - hope, frustration and lessons to learn. Authors' reply

artículo científico publicado en 2017

Editorial: progress towards a simple tool for screening for hepatic steatosis in the general population.

artículo científico publicado en 2017

Effects of Exercise on Liver Fat and Metabolism in Alcohol Drinkers.

artículo científico publicado en 2017

Efficacy and Safety of 8 Weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve, HCV-Infected Patients with APRI ≤ 1 in a Single-Arm, Open-Label, Multicenter Study

artículo científico publicado en 2019

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management

artículo científico publicado en 2014

Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial.

scientific article published on 10 August 2016

Hepatitis B in pregnancy

artículo científico publicado en 2013

Hepatitis C in a prison in the North East of England: what is the economic impact of the universal offer of testing and emergent medications?

artículo científico publicado en 2016

High rate of hepatitis C reinfection following antiviral treatment in the North East England Prisons

scientific article published on 05 December 2019

How big a problem is non-alcoholic fatty liver disease?

artículo científico publicado en 2011

Imagestream detection and characterisation of circulating tumour cells - A liquid biopsy for hepatocellular carcinoma?

artículo científico publicado en 2016

Impact Of Direct Acting Antiviral Agents On Liver Function In Patients With Chronic Hepatitis C Virus Infection

scientific article published on 26 September 2020

Implementation of a 'care bundle' improves the management of patients admitted to hospital with decompensated cirrhosis

artículo científico publicado en 2016

Improving access to treatment for patients with chronic hepatitis C through outreach.

artículo científico

Improving testing for hepatitis B before treatment with rituximab

artículo científico publicado en 2016

Increased cardiovascular risk and reduced quality of life are highly prevalent among individuals with hepatitis C

artículo científico publicado en 2020

Increased diagnosis and treatment of hepatitis C in prison by universal offer of testing and use of telemedicine

artículo científico publicado en 2018

Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis

artículo científico publicado en 2008

Lesson of the month 2: Severe reactivation of hepatitis B after immunosuppressive chemotherapy

artículo científico publicado en 2014

Lifestyle Behavior Change in Patients With Nonalcoholic Fatty Liver Disease: A Qualitative Study of Clinical Practice.

artículo científico publicado en 2017

Liver toxicity associated with sofosbuvir, an NS5A inhibitor and ribavirin use.

artículo científico publicado en 2015

Liver transplant listing for hepatitis C associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct acting antiviral therapy

artículo científico publicado en 2018

Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered.

artículo científico publicado en 2009

Management of decompensated cirrhosis

artículo científico publicado en 2018

Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging

artículo científico publicado en 2014

Non-alcoholic fatty liver disease: a practical approach to treatment

artículo científico publicado en 2014

Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification ⬇️

artículo científico publicado el 12 de agosto de 2013

Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease

artículo científico publicado en 2016

Postoperative methicillin-resistant Staphylococcus aureus enteritis following hysterectomy: a case report and review of the literature.

artículo científico publicado en 2005

Progress towards micro-elimination of hepatitis C in the custodial setting

artículo científico publicado en 2020

Reply to "Liver failure in human immunodeficiency virus - Hepatitis C virus coinfection treated with sofosbuvir, ledipasvir and antiretroviral therapy".

artículo científico publicado en 2015

Republished: Non-alcoholic fatty liver disease: a practical approach to treatment.

artículo científico publicado en 2015

Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.

artículo científico

Response to the NCEPOD report: development of a care bundle for patients admitted with decompensated cirrhosis—the first 24 h

artículo científico publicado en 2016

Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease

artículo científico publicado en 2014

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.

artículo científico publicado en 2010

Summary of the British Transplantation Society UK Guidelines for Hepatitis E and Solid Organ Transplantation.

artículo científico publicado en 2017

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

artículo científico publicado en 2014

Targeted case finding for hepatitis B using dry blood spot testing in the British-Chinese and South Asian populations of the North-East of England.

artículo científico publicado en 2013

The degree of hepatic steatosis associates with impaired cardiac and autonomic function

scientific article published on 13 February 2019

Treatment of refractory ascites with an automated low-flow ascites pump in patients with cirrhosis.

artículo científico publicado en 2017

Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: a qualitative study

artículo científico publicado en 2019

Lista de obras de

A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis

Acute hepatitis C in a nursing home resident

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.

An alcoholic patient who continues to drink: case presentation.

An alcoholic patient who continues to drink: case progression

Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?

Barriers and Facilitators to Mediterranean Diet Adoption by Patients with Non-alcoholic Fatty Liver Disease in Northern Europe

Care standards for non-alcoholic fatty liver disease in the United Kingdom 2016: a cross-sectional survey

Changing epidemiology of chronic liver disease among ethnic groups in the United States.

Convalescent plasma therapy for persistent hepatitis E virus infection

Decompensated alcohol related liver disease: acute management.

Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention Mapping

Distance to treatment as a factor for loss to follow up of hepatitis C patients in North East England

Editorial: NAFLD in Asia-clinical associations with advanced disease become clearer

Editorial: further evidence for the use of advanced magnetic resonance imaging techniques to monitor NAFLD.

Editorial: improving in-hospital management of decompensated cirrhosis by a 'care bundle' - hope, frustration and lessons to learn. Authors' reply

Editorial: progress towards a simple tool for screening for hepatic steatosis in the general population.

Effects of Exercise on Liver Fat and Metabolism in Alcohol Drinkers.

Efficacy and Safety of 8 Weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve, HCV-Infected Patients with APRI ≤ 1 in a Single-Arm, Open-Label, Multicenter Study

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management

Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial.

Hepatitis B in pregnancy

Hepatitis C in a prison in the North East of England: what is the economic impact of the universal offer of testing and emergent medications?

High rate of hepatitis C reinfection following antiviral treatment in the North East England Prisons

How big a problem is non-alcoholic fatty liver disease?

Imagestream detection and characterisation of circulating tumour cells - A liquid biopsy for hepatocellular carcinoma?

Impact Of Direct Acting Antiviral Agents On Liver Function In Patients With Chronic Hepatitis C Virus Infection

Implementation of a 'care bundle' improves the management of patients admitted to hospital with decompensated cirrhosis

Improving access to treatment for patients with chronic hepatitis C through outreach.

Improving testing for hepatitis B before treatment with rituximab

Increased cardiovascular risk and reduced quality of life are highly prevalent among individuals with hepatitis C

Increased diagnosis and treatment of hepatitis C in prison by universal offer of testing and use of telemedicine

Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis

Lesson of the month 2: Severe reactivation of hepatitis B after immunosuppressive chemotherapy

Lifestyle Behavior Change in Patients With Nonalcoholic Fatty Liver Disease: A Qualitative Study of Clinical Practice.

Liver toxicity associated with sofosbuvir, an NS5A inhibitor and ribavirin use.

Liver transplant listing for hepatitis C associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct acting antiviral therapy

Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered.

Management of decompensated cirrhosis

Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging

Non-alcoholic fatty liver disease: a practical approach to treatment

Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification ⬇️

Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease

Postoperative methicillin-resistant Staphylococcus aureus enteritis following hysterectomy: a case report and review of the literature.

Progress towards micro-elimination of hepatitis C in the custodial setting

Reply to "Liver failure in human immunodeficiency virus - Hepatitis C virus coinfection treated with sofosbuvir, ledipasvir and antiretroviral therapy".

Republished: Non-alcoholic fatty liver disease: a practical approach to treatment.

Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.

Response to the NCEPOD report: development of a care bundle for patients admitted with decompensated cirrhosis—the first 24 h

Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.

Summary of the British Transplantation Society UK Guidelines for Hepatitis E and Solid Organ Transplantation.

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

Targeted case finding for hepatitis B using dry blood spot testing in the British-Chinese and South Asian populations of the North-East of England.

The degree of hepatic steatosis associates with impaired cardiac and autonomic function

Treatment of refractory ascites with an automated low-flow ascites pump in patients with cirrhosis.

Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: a qualitative study